title: Infliximab and CT-P13 immunogenicity assessment in PLANETAS and PLANETRAS main and extension studies: utility of laboratory methods description.
authors.affiliation: Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
authors.forename: Francesca
authors.initials: F
authors.lastname: Meacci
authors.affiliation: Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
authors.forename: Mariangela
authors.initials: M
authors.lastname: Manfredi
authors.affiliation: Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
authors.forename: Maria
authors.initials: M
authors.lastname: Infantino
authors.affiliation: Immunology and Allergology Laboratory, San Giovanni di Dio Hospital, Florence, Italy.
authors.forename: Valentina
authors.initials: V
authors.lastname: Grossi
authors.affiliation: Rheumatology Unit, San Giovanni di Dio Hospital, Florence, Italy.
authors.forename: Maurizio
authors.initials: M
authors.lastname: Benucci
mesh_terms: D000911:Antibodies, Monoclonal / Q000276:immunology / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000503:physiopathology; D001688:Biological Products / Q000276:immunology / Q000627:therapeutic use*; D059451:Biosimilar Pharmaceuticals / Q000627:therapeutic use*; D015331:Cohort Studies; D057915:Drug Substitution; D005260:Female; D006801:Humans; D055261:Immunogenetic Phenomena; D000069285:Infliximab / Q000276:immunology / Q000627:therapeutic use*; D008297:Male; D061214:Patient Safety; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000276:immunology; D013548:Sweden; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D001688:Biological Products; D059451:Biosimilar Pharmaceuticals; C000591237:CT-P13; D000069285:Infliximab
keywords: Ankylosing Spondylitis; Anti-TNF; Arthritis